These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 31725418)

  • 41. Plasmablastic lymphoma versus anaplastic myeloma in a human immunodeficiency virus negative male: a diagnostic quandary.
    Jain BB; Majumdar A; Chowdhary KM
    Arch Iran Med; 2013 Oct; 16(10):608-10. PubMed ID: 24093145
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
    Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
    Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diffuse large B-cell lymphoma variants: an update.
    Sukswai N; Lyapichev K; Khoury JD; Medeiros LJ
    Pathology; 2020 Jan; 52(1):53-67. PubMed ID: 31735345
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Plasmablastic lymphoma in HIV-positive patients: an aggressive Epstein-Barr virus-associated extramedullary plasmacytic neoplasm.
    Dong HY; Scadden DT; de Leval L; Tang Z; Isaacson PG; Harris NL
    Am J Surg Pathol; 2005 Dec; 29(12):1633-41. PubMed ID: 16327436
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Aggressive large B-cell lymphoma with plasma cell differentiation: immunohistochemical characterization of plasmablastic lymphoma and diffuse large B-cell lymphoma with partial plasmablastic phenotype.
    Montes-Moreno S; Gonzalez-Medina AR; Rodriguez-Pinilla SM; Maestre L; Sanchez-Verde L; Roncador G; Mollejo M; García JF; Menarguez J; Montalbán C; Ruiz-Marcellan MC; Conde E; Piris MA
    Haematologica; 2010 Aug; 95(8):1342-9. PubMed ID: 20418245
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Plasmablastic lymphoma: a review.
    Rafaniello Raviele P; Pruneri G; Maiorano E
    Oral Dis; 2009 Jan; 15(1):38-45. PubMed ID: 18939960
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Plasmablastic Lymphoma. A State-of-the-Art Review: Part 1-Epidemiology, Pathogenesis, Clinicopathologic Characteristics, Differential Diagnosis, Prognostic Factors, and Special Populations.
    Bibas M
    Mediterr J Hematol Infect Dis; 2024; 16(1):e2024007. PubMed ID: 38223486
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasmablastic lymphoma with unfavorable chromosomal abnormalities related to plasma cell myeloma: A borderline case between plasmablastic lymphoma and plasmablastic plasma cell myeloma.
    Aoyama Y; Tsunemine H; Kodaka T; Oda N; Matsuoka H; Itoh T; Takahashi T
    J Clin Exp Hematop; 2017; 57(1):37-39. PubMed ID: 28679965
    [No Abstract]   [Full Text] [Related]  

  • 49. Diffuse large B-cell lymphomas with plasmablastic differentiation.
    Teruya-Feldstein J
    Curr Oncol Rep; 2005 Sep; 7(5):357-63. PubMed ID: 16091196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CD20-negative diffuse large B-cell lymphomas: biology and emerging therapeutic options.
    Castillo JJ; Chavez JC; Hernandez-Ilizaliturri FJ; Montes-Moreno S
    Expert Rev Hematol; 2015 Jun; 8(3):343-54. PubMed ID: 25641215
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Uniform expression of Notch1, suppressor of B-cell-specific gene expression, in plasmablastic lymphoma.
    Seegmiller AC; Wang HY; Hladik C; Chen W
    Arch Pathol Lab Med; 2011 Jun; 135(6):770-5. PubMed ID: 21631271
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Large B-cell lymphomas with plasmablastic differentiation: a biological and therapeutic challenge.
    Montes-Moreno S; Montalbán C; Piris MA
    Leuk Lymphoma; 2012 Feb; 53(2):185-94. PubMed ID: 21812534
    [TBL] [Abstract][Full Text] [Related]  

  • 53. KSHV/HHV-8 associated lymph node based lymphomas in HIV seronegative subjects. Report of two cases with anaplastic large cell morphology and plasmablastic immunophenotype.
    Carbone A; Gloghini A; Vaccher E; Marchetti G; Gaidano G; Tirelli U
    J Clin Pathol; 2005 Oct; 58(10):1039-45. PubMed ID: 16189148
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Primary central nervous system plasmablastic lymphoma presenting in human immunodeficiency virus-negative but Epstein-Barr virus-positive patient: a case report.
    Zhang LY; Lin HY; Gao LX; Li L; Tian YW; Liu ZQ; Shi XH; Liang ZY
    Diagn Pathol; 2012 May; 7():51. PubMed ID: 22568892
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Diagnosis of hematolymphoid malignancy by using effusion fluid cytology specimens: a study of 33 cases].
    Su XY; Xu X; Tang Y; Li GD
    Zhonghua Bing Li Xue Za Zhi; 2009 Aug; 38(8):542-6. PubMed ID: 20021966
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Plasmablastic lymphoma: An update.
    Bailly J; Jenkins N; Chetty D; Mohamed Z; Verburgh ER; Opie JJ
    Int J Lab Hematol; 2022 Sep; 44 Suppl 1(Suppl 1):54-63. PubMed ID: 36074710
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KSHV/HHV8-associated lymphomas.
    Carbone A; Gloghini A
    Br J Haematol; 2008 Jan; 140(1):13-24. PubMed ID: 17991301
    [TBL] [Abstract][Full Text] [Related]  

  • 58. CD-20 Negative Plasmablastic Lymphoma Lurking in the Shadow of a Leiomyoma - Diagnosis and Management.
    Bindra BS; Ramineni G; Sattar Y; Khillan R
    Cureus; 2019 Jul; 11(7):e5217. PubMed ID: 31565620
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Composite recurrent hodgkin lymphoma and diffuse large B-cell lymphoma: one clone, two faces.
    Huang Q; Wilczynski SP; Chang KL; Weiss LM
    Am J Clin Pathol; 2006 Aug; 126(2):222-9. PubMed ID: 16891197
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ALK-positive diffuse large B-cell lymphoma with the t(2;17)(p23;q23).
    Zhang D; Denley RC; Filippa DA; Teruya-Feldstein J
    Appl Immunohistochem Mol Morphol; 2009 Mar; 17(2):172-7. PubMed ID: 19521280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.